Houston Methodist Neurological Inst. Investigational Magnetic Device Zaps Glioblastoma Tumor in First-in-Human Trial

Houston Methodist Neurological Inst. Investigational Magnetic Device Zaps Glioblastoma Tumor in First-in-Human Trial

In a breakthrough clinical study, investigators at Houston Methodist Neurological Institute Department of Neurosurgery shrunk a deadly glioblastoma tumor by over 33% by using a helmet generating a noninvasive oscillating magnetic field that the patient wore on his head while administering the therapy in his own home. Unfortunately, the 53-year old patient died from an unrelated injury a month into the treatment, but 31% of the tumor mass dissipated during this very short duration. A brain autopsy confirmed a rapid response to the treatment.

The Study

The study was led by David S. Baskin, MD, FACS, FAANS, corresponding author and director of the Kenneth R. Peak Center for Brain and Pituitary Tumor Treatment in the Department of Neurology at Houston Methodist. Dr. Baskin acknowledged the courage of the patient and his family, for as the patient didn’t make it (again unrelated to the study treatment), the study team was able to “test and verify the potential effectiveness of the first noninvasive therapy for glioblastoma in the world.” The lead investigator further thanked the family, noting, “The family’s generous agreement to allow an autopsy after their loved ones’ untimely ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee